12/09/2026
GP leaders and experts are warning of an ‘increasingly urgent’ need to switch patients with diabetes from Levemir insulin before it is discontinued at the end of this year.
Local medical committees in London are among those writing to the integrated care board with patient safety concerns after pharmacies in the area are already reporting intermittent supply problems.
Manufacturer Novo Nordisk informed the Department of Health and Social Care in September 2024 that it would be withdrawing several older insulins including Levemir (insulin determir) in both its Penfill and Flexpen options.
Read more here: https://buff.ly/qlKYjnI